Abstract:Background and objective: To objectively evaluate the effects of probiotics supplement on glycemic control and lipid metabolism in patients with type 2 diabetes mellitus (T2DM).Material and methods: The randomized controlled trials (RCTs) with regard to the probiotics or synbiotics for the treatment of T2DM were collected through retrieving 5 databases from their establishment to March 2016. After study selection, quality assessment and data extraction were performed by 2 authors independently; and STATA software was used for statistical analysis. The level of evidence was evaluated by applying the GRADE system.Results: Twelve RCTs involving 770 participants were enrolled. The results of the meta-analysis showed that probiotics could significantly reduce fasting blood glucose by -11.27 mg/dL (95% CI -21.76 to -0.79; P<.001) and serum insulin concentration by -2.36 mu U/mL (95% CI -4.01 to -0.72; P=.005), but with no significant reduction on HbA(1c) (-0.19%; 95% CI -0.49 to 0.12; P=.23). Probiotics could significantly reduce HOMA-IR of T2DM patients (-1.05; 95% CI -1.52 to -0.59; P<.001). Nevertheless, the effect on QUICKI was negligible (0.00; 95% CI -0.00 to 0.01; P=.27). Results also confirmed the significant lowering effect of probiotics on total cholesterol (-8.49 mg/dL; 95% CI -15.24 to -1.73; P=.014) and triglycerides (TG; -23.66 mg/dL; 95% CI -40.26 to -7.05; P<.001), as well as the elevating effect on HDL-c (3.92 mg/dL; 95% CI 2.14 to5.7; P<.01). However, there was no significant change on LDL-c (-0.84 mg/dL; 95% CI -5.84 to 4.17; P=.75). Subgroup analysis was conducted for 2 outcomes, that is, serum insulin concentration and TG, whose heterogeneity was too high. The results showed multiple species of probiotics had stronger reduction effect on serum insulin concentration (-3.32 mu U/mL; 95% CI -5.89 to -0.75; P=.001) and TG (-25.94 mg/dL; 95% CI -65.33 to 13.44; P<.001). In addition, it also suggested that only the duration of treatment for >= 8 weeks could significantly reduce TG by -24.47 mg/dL (95% CI -40.15 to -8.78; P=.001). The duration of treatment for <8 weeks didn't result in significant reduction on TG (-4.31 mg/dL; 95% CI -37.69 to 29.06; P=.8). Finally, all the evidences were at moderate and low levels according to the GRADE system.Conclusion: As a kind of the potential biotherapeutics in the management of T2DM, probiotics can improve glucose control and lipid metabolism. (C) 2017 Elsevier Espana, S.L.U. All rights reserved.

Relationship between Probiotics and Type 2 Diabetes Mellitus: A Review

The Effects of Oral Probiotics on Type 2 Diabetes Mellitus (T2DM): A Clinical Trial Systematic Literature Review

Evaluation of probiotics for improving and regulation metabolism relevant to type 2 diabetes <i>in vitro</i>

Probiotics intervention for type 2 diabetes mellitus therapy: a review from proposed mechanisms to future prospects

Effects of probiotics on type II diabetes mellitus: a meta-analysis

Can Probiotics be used as an adjuvant thereby for diabetes - hope or hype? Narrative review of the literature

Effects of probiotics supplementation on glycemic profile in adults with type 2 diabetes mellitus: A grade-assessed systematic review and dose-response meta-analysis of randomized controlled trials

Do Probiotics Improve the Health Status of Individuals with Diabetes Mellitus? A Review on Outcomes of Clinical Trials

Probiotics, prebiotics, and synbiotics in type 1 diabetes mellitus: A systematic review and meta‐analysis of clinical trials

Probiotics have beneficial metabolic effects in patients with type 2 diabetes mellitus: a meta-analysis of randomized clinical trials

Effects of probiotics on gut microbiota in type 2 diabetes patients

Effects of Probiotics Supplement in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Trials.

Role of Probiotics in Diabetes Mellitus

The role of probiotics on microvascular complications of type-2 diabetes: Nephropathy and retinopathy

Research progress on relationship between type 2 diabetes, gut microbiota and probiotics

Role of natural products and intestinal flora on type 2 diabetes mellitus treatment

Meta-analysis of randomized controlled trials of the effects of probiotics on type 2 diabetes in adults

Mechanisms of probiotics to improve type 2 diabetes mellitus

Synbiotics and Gut Microbiota: New Perspectives in the Treatment of Type 2 Diabetes Mellitus

Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes

Type-2 Diabetes Mellitus and the Gut Microbiota: Systematic Review